Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Impact of antibiotic stewardship programs on Clostridium difficile infections (CDIs)
Joint Event on 2nd International Congress on Nosocomial and Healthcare Associated Infections & International Conference on Decontamination, Sterilization and Infection Control
Huda Mohammad Alshammari, and Salman Abdulaziz
Saudi Ministry of Health, Saudi ArabiaRashid Hospital, UAE
Clostridium difficile infections (CDIs) had become the major burden on the healthcare system. These infections are the result
of collateral damage to the normal bacterial flora of the human body, which is an inevitable complication of antibiotics use.
CDIs pose an immediate threat to the health of patients received antibiotics, more so than antimicrobial resistance. Considering
CDIs are nearly always complications of antibiotics use, the development of the program to ensure appropriate antibiotics use is
considered an important prevention intervention. The multidisciplinary managed program such as antimicrobial stewardship
has been initiated in healthcare facilities to control the misuse of antimicrobial therapies and reduce their complications.
Clinical pharmacist involved antimicrobial ward-round is designed to help limit CDIs and other hospital-associated organisms
by optimizing antimicrobial selection, dosing, de-escalation, and duration of antimicrobial therapy. Other activates such as
audit with feedback and antibiotic restriction also have been established to impact on the antimicrobial utilization. These
programs also incorporate the implementation of hospital-wide guidelines, staff education, enforcement of infection-control
policies, and the use of electronic medical records when possible to help control antimicrobial use. The literature strongly
emphasizes how antimicrobial stewardship programs impact on CDIs rates discusses experiences in designing, implementing,
monitoring, and follow-through of such programs. Literature shows the significant decrease in the use of parenteral broadspectrum
antibiotic and in the incidence of CDI.